158 related articles for article (PubMed ID: 38160516)
61. Application of radiomics based on chest CT-enhanced dual-phase imaging in the immunotherapy of non-small cell lung cancer.
Ma ZP; Li XL; Gao K; Zhang TL; Wang HD; Zhao YX
J Xray Sci Technol; 2023; 31(6):1333-1340. PubMed ID: 37840466
[TBL] [Abstract][Full Text] [Related]
62. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
Huang Y; Jiang X; Xu H; Zhang D; Liu LN; Xia YX; Xu DK; Wu HJ; Cheng G; Shi YH
Clin Radiol; 2023 Jan; 78(1):8-17. PubMed ID: 36192203
[TBL] [Abstract][Full Text] [Related]
63. Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade.
Vaidya P; Bera K; Patil PD; Gupta A; Jain P; Alilou M; Khorrami M; Velcheti V; Madabhushi A
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33051342
[TBL] [Abstract][Full Text] [Related]
64. A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer.
Xie Y; Zhao H; Guo Y; Meng F; Liu X; Zhang Y; Huai X; Wong Q; Fu Y; Zhang H
Eur Radiol; 2021 Aug; 31(8):6030-6038. PubMed ID: 33560457
[TBL] [Abstract][Full Text] [Related]
65. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
[TBL] [Abstract][Full Text] [Related]
66. Multi-parametric MRI-based radiomics for the diagnosis of malignant soft-tissue tumor.
Yue Z; Wang X; Yu T; Shang S; Liu G; Jing W; Yang H; Luo Y; Jiang X
Magn Reson Imaging; 2022 Sep; 91():91-99. PubMed ID: 35525523
[TBL] [Abstract][Full Text] [Related]
67. Radiomics nomogram for the prediction of Ki-67 index in advanced non-small cell lung cancer based on dual-phase enhanced computed tomography.
Sun H; Zhou P; Chen G; Dai Z; Song P; Yao J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9301-9315. PubMed ID: 37204513
[TBL] [Abstract][Full Text] [Related]
68. Radiomics of
Mu W; Tunali I; Gray JE; Qi J; Schabath MB; Gillies RJ
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1168-1182. PubMed ID: 31807885
[TBL] [Abstract][Full Text] [Related]
69. Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy.
Chang R; Qi S; Wu Y; Yue Y; Zhang X; Qian W
Cancer Imaging; 2023 Oct; 23(1):101. PubMed ID: 37867196
[TBL] [Abstract][Full Text] [Related]
70. Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC.
Hou S; Fan Y; Wang X; Su J; Ren M; Wu Y; Zhou J; Qu M; Luo Y; Jiang W
Acad Radiol; 2023 Jun; 30(6):1039-1046. PubMed ID: 35907759
[TBL] [Abstract][Full Text] [Related]
71. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
72. The value of CT radiomics features to predict visceral pleural invasion in ≤3 cm peripheral type early non-small cell lung cancer.
Wei SH; Zhang JM; Shi B; Gao F; Zhang ZX; Qian LT
J Xray Sci Technol; 2022; 30(6):1115-1126. PubMed ID: 35938237
[TBL] [Abstract][Full Text] [Related]
73. [18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.
Valentinuzzi D; Vrankar M; Boc N; Ahac V; Zupancic Z; Unk M; Skalic K; Zagar I; Studen A; Simoncic U; Eickhoff J; Jeraj R
Radiol Oncol; 2020 Jul; 54(3):285-294. PubMed ID: 32726293
[TBL] [Abstract][Full Text] [Related]
74. Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study.
Du Y; Cai M; Zha H; Chen B; Gu J; Zhang M; Liu W; Liu X; Liu X; Zong M; Li C
Eur Radiol; 2024 Jan; 34(1):136-148. PubMed ID: 37518678
[TBL] [Abstract][Full Text] [Related]
75. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on
Wei W; Jia G; Wu Z; Wang T; Wang H; Wei K; Cheng C; Liu Z; Zuo C
Jpn J Radiol; 2023 Apr; 41(4):417-427. PubMed ID: 36409398
[TBL] [Abstract][Full Text] [Related]
76. The value of CT radiomics combined with deep transfer learning in predicting the nature of gallbladder polypoid lesions.
Yin S; Ding N; Ji Y; Qiao Z; Yuan J; Chi J; Jin L
Acta Radiol; 2024 Jun; 65(6):554-564. PubMed ID: 38623640
[TBL] [Abstract][Full Text] [Related]
77. Prediction of recurrence risk factors in patients with early-stage cervical cancers by nomogram based on MRI handcrafted radiomics features and deep learning features: a dual-center study.
Zhang Y; Wu C; Du J; Xiao Z; Lv F; Liu Y
Abdom Radiol (NY); 2024 Jan; 49(1):258-270. PubMed ID: 37987856
[TBL] [Abstract][Full Text] [Related]
78. Differentiation of Lung Metastases Originated From Different Primary Tumors Using Radiomics Features Based on CT Imaging.
Shang H; Li J; Jiao T; Fang C; Li K; Yin D; Zeng Q
Acad Radiol; 2023 Jan; 30(1):40-46. PubMed ID: 35577699
[TBL] [Abstract][Full Text] [Related]
79. [Application of a Radiomics Model for Preding Lymph Node Metastasis in Non-small Cell Lung Cancer].
Zhu J; Xu WG; Xiao H; Zhou Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):373-378. PubMed ID: 31631606
[TBL] [Abstract][Full Text] [Related]
80. Radiomics of Spinal Metastases Originating From Primary Nonsmall Cell Lung Cancer or Breast Cancer and Ability to Predict Epidermal Growth Factor Receptor Mutation/Ki-67 Levels.
Niu S; Zhang H; Wang X; Jiang W
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):643-649. PubMed ID: 37380152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
